Biogen Inc. (BIIB) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Biogen Inc BIIB
$204.53
▲ +2.59%
(+$5.17)
Index member:
S&P 500
Open
$199.33
Prev Close
$199.36
Day Range
$198.86 – $205.97
52W Range
$119.18 – $202.41
Market Cap
$29.22B
P/E (TTM)
21.45
Beta
0.17
EPS (TTM)
$9.32
📋 Company Profile
| Industry | Biotechnology |
| Sector | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1991-09-17 |
| Shares Out. | 146,760,000 |
| Website | biogen.com/ ↗ |
| Phone | 13023513367 |
Biogen Inc is a publicly traded company under the ticker symbol BIIB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
43 analysts (2026-05-01)
📰 Latest News for BIIB
Transcript : Biogen Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11
3 Value Stocks We Approach with Caution
Is Biogen Inc. (BIIB) one of the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?
Assessing Biogen (BIIB) Valuation After Recent Share Price Momentum And Mixed Long Term Returns
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy
FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended